Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into ...

PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...

A novel MRI-based ‘aging’ clock may offer a simple way to identify patients whose biological age is outpacing their ...

In the moderate stage, patients may become suspicious, forget the date, have sleep issues, lose bladder or bowel control, and need more support with daily tasks. In later stages of Alzheimer’s, they ...

A scan that can detect Alzheimer’s disease before memory loss begins is now available in the UAE for the first time. The amyloid PET scan, recently launched at Cleveland Clinic Abu Dhabi, is a ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

A new tool developed by researchers can estimate how fast someone is aging by analyzing a single MRI brain scan, predicting ...

Zervimesine (CT1812) is an investigational, oral, once-daily pill in development for the treatment of CNS diseases such as Alzheimer’s disease and dementia with Lewy bodies (DLB).

USC researchers have identified a new brain imaging benchmark that may improve how researchers classify biologically meaningful changes associated with Alzheimer’s disease, especially in ...

In recent years, PET scans have become an important tool to help detect the presence of amyloid plaques – a hallmark of Alzheimer's – and other metabolic changes associated with the disease.

New scans help Sarasota Memorial doctors identify markers for Alzheimer's disease While the tools for DaTscans and PET scans are not new, some of the applications and upgrades over the past year ...